Literature DB >> 10880383

Endothelin receptor subtype distribution predisposes coronary arteries to damage.

C S Louden1, P Nambi, M A Pullen, R A Thomas, L A Tierney, H A Solleveld, L W Schwartz.   

Abstract

Several vasoactive drugs that lower blood pressure and increase heart rate induce regional cardiotoxicity in the dog, most frequently of right coronary arteries and right atrium. The basis for this selective damage is thought to result from local changes in vascular tone and blood flow. Administration of an endothelin receptor antagonist (ETRA, SB 209670) to dogs induced damage most frequent and severe in the right coronary artery and right atrium. Because site predisposition may correlate with distribution of vasoactive receptors, the objectives of this study were to map endothelin (ET) receptor distribution and density within regions of dog heart using both gene (mRNA) and protein expression endpoints for dog ET(A) and ET(B) receptors, and, additionally, correlate ET receptor subtype density with regional cardiac blood flow. A 10- to 15-mmHg reduction in mean arterial pressure with a concomitant increase in heart rate (10-20%), a six- and twofold increase in regional blood flow to the right and left atrium, respectively, and acute hemorrhage, medial necrosis, and inflammation were observed in the right coronary arteries and arteries of the right atrium after ETRA infusion for 5 days. Radioligand protein binding to quantify both ET receptors in normal dog heart indicated a twofold greater density of ET receptors in atrial regions versus ventricular regions. Importantly, ET receptor density in coronary arteries was markedly (about five- to sixfold) increased above that in atrial or ventricular tissues. ET receptor subtype characterization indicated ET(B) receptors were three times more prevalent in right coronary arteries compared to left coronary arteries and in situ hybridization confirmed localization of ET(B) in vascular smooth muscle. ET(A) receptor density was comparable in right and left coronary arteries. Quantitative real-time polymerase chain reaction for ET(A) and ET(B) receptor mRNA transcripts supported the site prevalence for message distribution. Consequently, the composite of protein and message expression profiles for ET(A) and ET(B) receptors indicated a disproportionate distribution of ET(B) receptors within right coronary artery of dog and this, along with functional measures of blood flow after ETRA infusion indicated a predisposition for exaggerated pharmacological responses and subsequent damage to right coronary arteries by ET and/or ETRAs.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10880383      PMCID: PMC1850223          DOI: 10.1016/S0002-9440(10)64524-5

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  48 in total

1.  A novel potent vasoconstrictor peptide produced by vascular endothelial cells.

Authors:  M Yanagisawa; H Kurihara; S Kimura; Y Tomobe; M Kobayashi; Y Mitsui; Y Yazaki; K Goto; T Masaki
Journal:  Nature       Date:  1988-03-31       Impact factor: 49.962

2.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

3.  Coronary arteriopathy in monkeys following administration of CI-1020, an endothelin A receptor antagonist.

Authors:  M A Albassam; A L Metz; N J Gragtmans; L M King; G E Macallum; H Hallak; E J McGuire
Journal:  Toxicol Pathol       Date:  1999 Mar-Apr       Impact factor: 1.902

4.  Effects of short-term and long-term theobromine administration to male dogs.

Authors:  J H Gans; R Korson; M R Cater; C C Ackerly
Journal:  Toxicol Appl Pharmacol       Date:  1980-05       Impact factor: 4.219

5.  Whole body and regional hemodynamic effects of minoxidil in the conscious dog.

Authors:  S J Humphrey; G R Zins
Journal:  J Cardiovasc Pharmacol       Date:  1984 Nov-Dec       Impact factor: 3.105

6.  Cardiotoxicity of a new inotrope/vasodilator drug (SK&F 94120) in the dog.

Authors:  J H Harleman; E C Joseph; R J Eden; T F Walker; I R Major; M S Lamb
Journal:  Arch Toxicol       Date:  1986-05       Impact factor: 5.153

7.  Cardiovascular alterations in dogs treated with hydralazine.

Authors:  G M Mesfin; G G Shawaryn; M J Higgins
Journal:  Toxicol Pathol       Date:  1987       Impact factor: 1.902

8.  Validity of microsphere depositions for regional myocardial flows.

Authors:  J B Bassingthwaighte; M A Malone; T C Moffett; R B King; S E Little; J M Link; K A Krohn
Journal:  Am J Physiol       Date:  1987-07

9.  Cardiovascular effects of radioactive microsphere suspensions and Tween 80 solutions.

Authors:  R W Millard; H Baig; S F Vatner
Journal:  Am J Physiol       Date:  1977-03

10.  The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes.

Authors:  A Inoue; M Yanagisawa; S Kimura; Y Kasuya; T Miyauchi; K Goto; T Masaki
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

View more
  1 in total

1.  Evaluation of von Willebrand factor and von Willebrand factor propeptide in models of vascular endothelial cell activation, perturbation, and/or injury.

Authors:  David A Brott; Anne Katein; Heath Thomas; Michael Lawton; Robert R Montgomery; Rudy J Richardson; Calvert S Louden
Journal:  Toxicol Pathol       Date:  2014-02-04       Impact factor: 1.902

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.